Ixazomib Impurity 51 CAS 50-75-9
| CAS No. | 50-75-9 |
| Molecular Formula | C7H3Cl3O2 |
| Molecular Weight | 225.46 g/mol |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
Ixazomib Impurity 51 (CAS 50-75-9) is a certified pharmaceutical impurity reference standard with the molecular formula C7H3Cl3O2 and a molecular weight of 225.46 g/mol.
Structurally, Ixazomib Impurity 51 (C7H3Cl3O2) contains a carboxylic acid group, a hydroxyl group, an ether linkage, chlorine substitution, an aromatic ring system. The molecule exhibits a degree of unsaturation (DBE) of 5.0, corresponding to approximately 5 ring(s) or double-bond equivalent(s). With a molecular weight of 225.46 g/mol, it falls into the medium-molecular-weight range. The aromatic system may exhibit native fluorescence, enabling detection with a fluorescence detector (FLD).
Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.
CATO manufactures Ixazomib Impurity 51 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C7H3Cl3O2 |
| Molecular Weight | 225.46 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor, low volatility) |
| Purity | 97%+ |
| Storage | Store at room temperature, keep tightly closed to prevent evaporation |
| Solubility (reference) | Soluble in methanol, acetonitrile, DMSO, water (slightly soluble) |
| Stability | May oxidize slowly on prolonged air exposure; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 5.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1957 |
| Halogen Content | Cl-containing |
Related Ixazomib Standards
Recommended Standards
- 2,3,6-Trichlorobenzoic Acid (CAS 50-31-7)
- 3,5-Dichloro-4-hydroxybenzoyl chloride (CAS 59595-92-5)
- 2,4,6-Trichlorobenzoic Acid (CAS 50-43-1)
- 3,5,6-Trichlorosalicylaldehyde (CAS 23602-65-5)
- Relebactam Impurity 76 (CAS CATO-C4X-214476)
- Apremilast Impurity 40 (CAS 2055542-18-0)
- Paroxetine Impurity 57 (CAS CATO-C4X-103557)
- (3,4-Bis(benzyloxy)phenyl)methanol (CAS 1699-58-7)
- N-[(1S,2R)-1-Benzyl-2-hydroxy-2-((2R,4R)-4-methoxy-pyrrolidin-2-yl)-ethyl]-3-[(R)-2-(4-methyl-thiazol-2-yl)-pyrrolidine-1-carbonyl]-5-oxazol-2-yl-benzamide (CAS 1221263-97-3)
- S-Baclofen Hydrochloride (CAS 63701-56-4)
- Difenzoquat Methyl Sulfate (CAS 43222-48-6)
- 2-Methoxy-1-(1H-1,2,3-triazol-4-yl)ethan-1-amine (CAS 120829-17-6)
- N,N-dimethyl-N-(2-(triethoxysilyl)ethyl)dodecan-1-aminium chloride (CAS 62117-37-7)
- Semaglutide Impurity 6 (CAS 62-57-7)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com